연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1750 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Jia, Shidong | Jia, S | 2 | |||||||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Du, Pan | Du, P | 3 | |||||||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Lee, Jeeyeon | Lee, J | 4 | |||||||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Kang, Byeongju | Kang, B | 5 | |||||||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Lee, In Hee | Lee, IH | 6 | |||||||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Chae, Yee Soo | Chae, YS | 7 | |||||||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Park, Ho Yong | Park, HY | 8 | |||||||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Park, Jee-Young Nora | Park, JYN | 9 | AAA-1951-2022 | Park, Jung Hwan | |||||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Chung, Liam Il Young | Chung, LIY | 10 | IQU-0821-2023 | Chung, Liam Il-Young | |||||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Zheng, Tiantian | Zheng, T | 11 | |||||||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Tan, Lu | Tan, L | 12 | |||||||
| Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | Chae, Young Kwang | Chae, YK | 13 | |||||||
| Progression-directed therapy in patients with oligoprogressive castration-resistant prostate cancer | Lee, Jun Nyung | Lee, JN | 1 | Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea | 0000-0002-6342-9846 | Lee, Jun Nyung | tgkwon@knu.ac.kr; | |||
| Progression-directed therapy in patients with oligoprogressive castration-resistant prostate cancer | Kim, Mi Young | Kim, MY | 2 | Kyungpook Natl Univ, Dept Radiat Oncol, Chilgok Hosp, Daegu, South Korea | JTT-7430-2023 | Kim, Mi young | tgkwon@knu.ac.kr; | |||
| Progression-directed therapy in patients with oligoprogressive castration-resistant prostate cancer | Kang, Jae Hoon | Kang, JH | 3 | Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea | tgkwon@knu.ac.kr; |
페이지 이동: